Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-272-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-10-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Protocol to the Euro-Mediterranean Agreement establishing an association between the EC and Israel on Conformity Assessment and Acceptance of Industrial Products (CAA) (debate)2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20121023.17.2-272-000"2
lpv:hasSubsequent	lp_eu:2012-10-23-Speech-2-273-0002
lpv:speaker	lp:Yannick Jadot2
lpv:spokenAs	member; G/EFA (2009-07-14--2014-06-30)3 substitute; ITRE (2012-01-19--2014-06-30)3 vice-chair; INTA (2012-01-25--2014-06-30)3 substitute; Delegation for relations with the countries of South Asia (2009-09-16--2014-06-30)3 unknown; Europe Écologie (2009-07-14--2014-06-30)3 substitute; Delegation for relations with Afghanistan (2011-09-15--2014-06-30)3
lpv:translated text	". As you know, it is extremely difficult to trace the origin of all of the products that come from Israel. Therefore, even if there is no definitive proof today that pharmaceutical products are produced in certain territories, that does not mean that that will be the case in the future, especially when there is a desire to expand the settlements and there may be other industrial products that would not offer a guarantee that they are not manufactured in the Occupied Territories. Sir, do not hesitate to look at the voting list of the Greens for every vote we hold on trade agreements: you will see that we are consistent with regard to respect for human rights, the environment and social rights."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph